Which pharmacologic agents are safe for managing acute agitation in a pregnant patient?

Managing Acute Agitation in Pregnancy: Pharmacologic Agents

For acute agitation in pregnant patients requiring medication, haloperidol (1.25-5 mg IM) is the preferred first-line agent, with promethazine (25 mg IM) as an alternative antihistamine option for mild-to-moderate agitation. 1, 2

First-Line Pharmacologic Options

High-Potency Typical Antipsychotics (Preferred)

Haloperidol is the most frequently utilized and best-studied agent for managing acute agitation during pregnancy 1, 2, 3. Real-world practice data from tertiary care centers demonstrates:

• Intramuscular haloperidol 1.25 mg was used in 14.69% of cases
• Intramuscular haloperidol 2.5-5 mg for more severe agitation
• Often combined with promethazine 25 mg for enhanced efficacy 2

Why haloperidol is preferred: High-potency typical antipsychotics have neutral hemodynamic effects, avoiding the hypotension risk that could compromise uteroplacental perfusion 1. Haloperidol has decades of safety data in pregnancy, though it carries risk of extrapyramidal symptoms.

Antihistamines (For Mild-Moderate Agitation)

Diphenhydramine or promethazine are effective sedating agents with minimal adverse fetal effects 1, 2:

• Promethazine 25 mg IM was the single most common treatment (32.20% of cases) in one large tertiary center study 2
• Diphenhydramine is specifically recommended for mild-to-moderate agitation 1
• Lower risk profile than antipsychotics or benzodiazepines

Second-Line Options

Second-Generation Antipsychotics

Risperidone is the preferred atypical antipsychotic when first-line agents fail 1, 3:

• Used as second-line therapy after haloperidol
• Olanzapine 5 mg was used in 10.17% of cases 2
• Quetiapine 50 mg used in 1.13% of cases 2

These have less extrapyramidal side effects than haloperidol but less pregnancy safety data.

Agents to Use Sparingly or Avoid

Benzodiazepines (Use With Extreme Caution)

Benzodiazepines have demonstrated adverse fetal outcomes and should be reserved for refractory cases only 1:

• Lorazepam 2 mg (oral, IM, or IV) was used in only 14.68% combined of agitation cases 2
• Risk of fetal sedation, respiratory depression, and potential teratogenicity
• If absolutely necessary, use lowest effective dose

Ketamine (Avoid)

Ketamine has demonstrated adverse fetal outcomes and should be avoided 1

Clinical Algorithm for Drug Selection

Step 1: Assess Severity

• Mild-moderate agitation → Promethazine 25 mg IM or diphenhydramine
• Moderate-severe agitation → Haloperidol 1.25-2.5 mg IM
• Severe agitation unresponsive to initial dose → Haloperidol 5 mg IM or haloperidol + promethazine combination

Step 2: If First-Line Fails

• Consider risperidone or olanzapine 5 mg
• Avoid escalating to benzodiazepines unless absolutely necessary

Step 3: Dosing Principles

• Use the lowest effective dose - fetal risk with multiple doses remains unknown 1
• Single-dose administration preferred over repeated dosing
• Monitor for maternal hypotension and fetal heart rate changes

Critical Safety Considerations

Always Attempt First

Verbal de-escalation was effective in 3.95% of cases without any medication 2. Nonpharmacologic management should always be attempted before medications, but ED visits for agitation often require medical management 1.

Obstetric Emergency Status

Agitation during pregnancy must be treated as an obstetric emergency - the maternal distress jeopardizes both patient and fetus 1, 4. Do not delay treatment due to pregnancy concerns; untreated severe agitation poses greater risk than appropriate medication use.

Physical Restraint

In the tertiary care study, no patients required physical restraint when appropriate pharmacologic management was used 2. Chemical restraint is safer than physical restraint in pregnancy.

Common Pitfalls to Avoid

1. Delaying treatment due to pregnancy concerns - untreated agitation is more dangerous
2. Using benzodiazepines as first-line - they have worse fetal outcomes than haloperidol 1
3. Excessive dosing - start low, as pregnancy alters drug metabolism
4. Ignoring hemodynamic effects - avoid agents causing hypotension (verapamil, low-potency antipsychotics)
5. Failing to identify medical causes - always rule out eclampsia, metabolic derangements, substance intoxication

Monitoring Requirements

• Continuous fetal heart rate monitoring when feasible
• Maternal vital signs, especially blood pressure
• Watch for extrapyramidal symptoms with haloperidol (treat with diphenhydramine if needed)

Multidisciplinary Consultation

Early consultation with obstetrics and psychiatry services is essential 4. Consultation-liaison psychiatry plays a critical role in managing psychotropic regimens during pregnancy 5.